192 related articles for article (PubMed ID: 37946213)
1. Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway/O-GlcNAc cycling and aggravates Alzheimer's disease neuropathology in adult zebrafish.
Park J; Kim DY; Hwang GS; Han IO
J Neuroinflammation; 2023 Nov; 20(1):257. PubMed ID: 37946213
[TBL] [Abstract][Full Text] [Related]
2. REM Sleep Deprivation Impairs Learning and Memory by Decreasing Brain O-GlcNAc Cycling in Mouse.
Kim SM; Zhang S; Park J; Sung HJ; Tran TT; Chung C; Han IO
Neurotherapeutics; 2021 Oct; 18(4):2504-2517. PubMed ID: 34312767
[TBL] [Abstract][Full Text] [Related]
3. Hexosamine biosynthetic pathway and
Kim DY; Park J; Han IO
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
[TBL] [Abstract][Full Text] [Related]
4. Caffeine-induced protein kinase A activation restores cognitive deficits induced by sleep deprivation by regulating
Tran TT; Park J; Kim DY; Han IO
Am J Physiol Cell Physiol; 2024 Mar; 326(3):C978-C989. PubMed ID: 38314722
[TBL] [Abstract][Full Text] [Related]
5. Repeated hypoxia exposure induces cognitive dysfunction, brain inflammation, and amyloidβ/
Park J; Jung S; Kim SM; Park IY; Bui NA; Hwang GS; Han IO
J Cereb Blood Flow Metab; 2021 Nov; 41(11):3111-3126. PubMed ID: 34176340
[TBL] [Abstract][Full Text] [Related]
6. Sleep deprivation impairs learning and memory by decreasing protein O-GlcNAcylation in the brain of adult zebrafish.
Lee Y; Park J; Kim SM; Nam K; Lee W; Cho H; Han IO
FASEB J; 2020 Jan; 34(1):853-864. PubMed ID: 31914627
[TBL] [Abstract][Full Text] [Related]
7. Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation.
Cong R; Sun L; Yang J; Cui H; Ji X; Zhu J; Gu JH; He B
Biomed Pharmacother; 2021 Jun; 138():111477. PubMed ID: 33765582
[TBL] [Abstract][Full Text] [Related]
8. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
9. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Yuzwa SA; Vocadlo DJ
Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
[TBL] [Abstract][Full Text] [Related]
11. Glucosamine regulates hepatic lipid accumulation by sensing glucose levels or feeding states of normal and excess.
Park J; Lee Y; Jung EH; Kim SM; Cho H; Han IO
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158764. PubMed ID: 32663610
[TBL] [Abstract][Full Text] [Related]
12. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
14. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
15. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
[TBL] [Abstract][Full Text] [Related]
17. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
Parker MP; Peterson KR; Slawson C
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
[TBL] [Abstract][Full Text] [Related]
19. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
Ryu IH; Lee KY; Do SI
Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
[TBL] [Abstract][Full Text] [Related]
20. Forskolin rescues hypoxia-induced cognitive dysfunction in zebrafish with potential involvement of O-GlcNAc cycling regulation.
Nguyen QTN; Park J; Kim DY; Tran DT; Han IO
Biochem Pharmacol; 2024 Mar; 221():116032. PubMed ID: 38281601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
